502 related articles for article (PubMed ID: 28362071)
21. Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals.
Arnbjerg CJ; Vestad B; Hov JR; Pedersen KK; Jespersen S; Johannesen HH; Holm K; Halvorsen B; Fallentin E; Hansen AE; Lange T; Kjær A; Trøseid M; Fischer BM; Nielsen SD
J Acquir Immune Defic Syndr; 2018 Aug; 78(4):450-457. PubMed ID: 29874201
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the intestinal microbiota in MSM with HIV infection.
Fu Y; Ke S; Tang G; Guo Q; Guo Q; Wang Z; Leng R; Fan Y
BMC Microbiol; 2024 Jun; 24(1):192. PubMed ID: 38831399
[TBL] [Abstract][Full Text] [Related]
23. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
[TBL] [Abstract][Full Text] [Related]
24. Dynamic Changes in Breast Milk Microbiome in the Early Postpartum Period of Kenyan Women Living with HIV Are Influenced by Antibiotics but Not Antiretrovirals.
Maqsood R; Skidmore PT; Holland LA; Au JL; Khan AK; Wu LI; Ma N; Begnel ER; Chohan BH; Adhiambo J; John-Stewart G; Kiarie J; Kinuthia J; Chung MH; Richardson BA; Slyker J; Lehman DA; Lim ES
Microbiol Spectr; 2022 Apr; 10(2):e0208021. PubMed ID: 35384692
[TBL] [Abstract][Full Text] [Related]
25. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
[TBL] [Abstract][Full Text] [Related]
26. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
27. High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy.
Kaur US; Shet A; Rajnala N; Gopalan BP; Moar P; D H; Singh BP; Chaturvedi R; Tandon R
Sci Rep; 2018 Dec; 8(1):17679. PubMed ID: 30518941
[TBL] [Abstract][Full Text] [Related]
28. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
29. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
[TBL] [Abstract][Full Text] [Related]
30. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
Patel N; Abdelsayed S; Veve M; Miller CD
Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
[TBL] [Abstract][Full Text] [Related]
31. Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.
Rebeiro PF; Jenkins CA; Bian A; Lake JE; Bourgi K; Moore RD; Horberg MA; Matthews WC; Silverberg MJ; Thorne J; Mayor AM; Lima VD; Palella FJ; Saag MS; Althoff KN; Gill MJ; Wong C; Klein MB; Crane HM; Marconi VC; Shepherd BE; Sterling TR; Koethe JR
Clin Infect Dis; 2021 Oct; 73(7):e2234-e2242. PubMed ID: 32936919
[TBL] [Abstract][Full Text] [Related]
32. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
[TBL] [Abstract][Full Text] [Related]
33. Growth arrest-specific 6 protein in HIV-infected patients: Determination of plasma level and different antiretroviral regimens.
Lin TY; Lin FH; Hung CC; Liu CL; Hsiao YC; Lee CH; Wang NC
J Microbiol Immunol Infect; 2021 Oct; 54(5):926-933. PubMed ID: 34210628
[TBL] [Abstract][Full Text] [Related]
34. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
[TBL] [Abstract][Full Text] [Related]
35. Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria.
Nowak RG; Bentzen SM; Ravel J; Crowell TA; Dauda W; Ma B; Liu H; Blattner WA; Baral SD; Charurat ME;
AIDS; 2017 Mar; 31(6):857-862. PubMed ID: 28118207
[TBL] [Abstract][Full Text] [Related]
36. The impact of
Machiavelli A; Duarte RTD; Pires MMS; Zárate-Bladés CR; Pinto AR
Gut Microbes; 2019; 10(5):599-614. PubMed ID: 30657007
[TBL] [Abstract][Full Text] [Related]
37. Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens.
Baltazar-Díaz TA; Amador-Lara F; Andrade-Villanueva JF; González-Hernández LA; Cabrera-Silva RI; Sánchez-Reyes K; Álvarez-Zavala M; Valenzuela-Ramírez A; Del Toro-Arreola S; Bueno-Topete MR
Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110374
[TBL] [Abstract][Full Text] [Related]
38. Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
Tincati C; Merlini E; Braidotti P; Ancona G; Savi F; Tosi D; Borghi E; Callegari ML; Mangiavillano B; Barassi A; Bulfamante G; d'Arminio Monforte A; Romagnoli S; Chomont N; Marchetti G
AIDS; 2016 Apr; 30(7):991-1003. PubMed ID: 27028142
[TBL] [Abstract][Full Text] [Related]
39. Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease.
El-Far M; Tremblay CL
Curr Opin HIV AIDS; 2018 Jan; 13(1):38-44. PubMed ID: 29045253
[TBL] [Abstract][Full Text] [Related]
40. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
